Skip to main content
. 2020 Apr 10;10(2):e13. doi: 10.5415/apallergy.2020.10.e13

Table 2. Serum IgE and eosinophil count before and after 2 months of mepolizumab treatment.

Case IgE & Eos Pre 2 Months
1 IgE (IU/mL) 1,770 1,815
Eos (/μL) 440 30
2 IgE (IU/mL) 948 1,070
Eos (/μL) 371 50
3 IgE (IU/mL) - -
Eos (/μL) 252 39

IgE was not measured in case 3 because of possible influence of omalizumab.

Eos, eosinophils.